|
Volumn 92, Issue 12, 2001, Pages 2985-2992
|
Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma
|
Author keywords
Metastasis; Recurrence; Survival; Transforming growth factor 1; Transitional cell carcinoma
|
Indexed keywords
TRANSFORMING GROWTH FACTOR BETA1;
ADULT;
AGED;
ARTICLE;
BLADDER CARCINOMA;
CANCER INVASION;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CYSTECTOMY;
FEMALE;
HUMAN;
HUMAN TISSUE;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
TRANSITIONAL CELL CARCINOMA;
TREATMENT OUTCOME;
ADULT;
AGED;
CYSTECTOMY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
TRANSFORMING GROWTH FACTOR BETA;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0035892767
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5 Document Type: Article |
Times cited : (82)
|
References (27)
|